BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38812943)

  • 1. The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.
    Al Sulaiman K; Alkofide HA; AlFaifi ME; Aljohani SS; Al Harthi AF; Alqahtani RA; Alanazi AM; Nazer LH; Al Shaya AI; Aljuhani O
    Saudi Pharm J; 2024 Jun; 32(6):102094. PubMed ID: 38812943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker treatment in the critically ill: a systematic review and meta-analysis.
    Heliste M; Pettilä V; Berger D; Jakob SM; Wilkman E
    Ann Med; 2022 Dec; 54(1):1994-2010. PubMed ID: 35838226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin C in critically ill patients with sepsis and septic shock: A meta-analysis.
    Feng F; Yang H; Yang W; Li M; Chang X; Chen Y
    Sci Prog; 2021; 104(1):36850421998175. PubMed ID: 33787414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.
    Zhong L; Ji XW; Wang HL; Zhao GM; Zhou Q; Xie B
    J Intensive Care; 2020 Oct; 8(1):83. PubMed ID: 33292658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L; Wang P; Li C; Xie J
    Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
    Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
    Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of β-blockers in patients with septic shock: a meta analysis].
    Yu YW; Sun TW; Wan YD; Liu ZQ; Kan QC
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):570-4. PubMed ID: 26902201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.
    Warttig S; Alderson P; Evans DJ; Lewis SR; Kourbeti IS; Smith AF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012404. PubMed ID: 29938790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressors for shock.
    Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
    Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressors in septic shock: a systematic review and network meta-analysis.
    Zhou F; Mao Z; Zeng X; Kang H; Liu H; Pan L; Hou PC
    Ther Clin Risk Manag; 2015; 11():1047-59. PubMed ID: 26203253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it time to reposition vasopressors and inotropes in sepsis?
    Rudis MI; Basha MA; Zarowitz BJ
    Crit Care Med; 1996 Mar; 24(3):525-37. PubMed ID: 8625645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.
    Ruslan MA; Baharuddin KA; Noor NM; Yazid MB; Noh AYM; Rahman A
    West J Emerg Med; 2021 Feb; 22(2):196-203. PubMed ID: 33856300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of norepinephrine versus dopamine for septic shock: a meta analysis].
    Zhou FH; Song Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):449-54. PubMed ID: 24021037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropes and vasopressors are associated with increased short-term mortality but not long-term survival in critically ill patients.
    Motiejunaite J; Deniau B; Blet A; Gayat E; Mebazaa A
    Anaesth Crit Care Pain Med; 2022 Feb; 41(1):101012. PubMed ID: 34952218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressors for hypotensive shock.
    Gamper G; Havel C; Arrich J; Losert H; Pace NL; Müllner M; Herkner H
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD003709. PubMed ID: 26878401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis.
    Li Y; Li H; Zhang D
    Crit Care; 2020 Aug; 24(1):488. PubMed ID: 32762765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.